Research Article
Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking
Table 1
Active compounds of SQP against NAFLD.
| Mol ID | Ingredient | Degree | OB (%) | DL |
| MOL000098 | Quercetin | 41 | 54.83 | 0.24 | MOL000422 | Kaempferol | 22 | 65.31 | 0.35 | MOL000449 | Stigmasterol | 10 | 43.87 | 0.76 | MOL000546 | Diosgenin | 5 | 43.78 | 0.76 | MOL008457 | Tetrahydroalstonine | 4 | 32.42 | 0.81 | MOL002392 | Deltoin | 4 | 46.69 | 0.37 | MOL000358 | Beta-sitosterol | 3 | 36.91 | 0.75 | MOL000492 | (+)-Catechin | 2 | 42.36 | 0.37 | MOL004576 | Taxifolin | 2 | 57.84 | 0.27 | MOL000322 | Kadsurenone | 1 | 37.57 | 0.71 | MOL005440 | Isofucosterol | 1 | 38.16 | 0.54 | MOL005430 | Hancinone C | 1 | 61.47 | 0 38 | MOL007374 | 5- ((5- (4-methoxyphenyl)-2furyl)methylene)Barbiturc acid | 1 | 31.14 | 0.54 | MOL001559 | Piperlonguminine | 1 | 60.51 | 0.27 | MOL003137 | Leucanthoside MOL005440 | 1 | 32.12 | 0.78 |
|
|